Get started
Work

Multimodality Therapy in Patients With Primary Pericardial Mesothelioma

Year: 2022
Type: article
Study design: Observational Study
DOI: 10.1016/j.jtho.2022.08.017
Authors: Michael Offin, Dilanka L. De Silva, Jennifer L. Sauter, Jacklynn V. Egger, Ellen Yorke, Prasad S. Adusumilli, Andreas Rimner, Valerie W. Rusch, Marjorie G. Zauderer
Language: English
Field: Medicine
Open Access status: bronze
Funders: U.S. Department of Defense, Boehringer Ingelheim, Mesothelioma Applied Research Foundation, American Society for Radiation Oncology, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Memorial Sloan-Kettering Cancer Center, Varian Medical Systems, Novocure, Atara Biotherapeutics, Aldeyra Therapeutics, MedImmune, PharmaMar, National Institutes of Health, Genentech, Merck Sharp and Dohme, National Cancer Institute
Awards: G1229558712, G2051006376, G289723095, G3994034673, G4102770861, G6516949535, G7341898602, G9000003249, Cancer Center Support Grant, G954026598
OpenAlex ID: W4294676265
FWCI: 1.826
Cites: 16
Cited by: 18
Related to: 10